CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Filters
1 research outputs found
Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial
Author
BIP Study Group
David Kallend
+11 more
Eli M. Roth
Evan A. Stein
ILLUMINATE Investigators
ILLUSTRATE Investigators
James M. Rhyne
Jennifer G. Robinson
on behalf of the dal-OUTCOMES Committees Investigators
RADIANCE 1 Investigators
RADIANCE 2 Investigators
Tracy Burgess
VA-HIT Study Group
Publication venue
Oxford University Press
Publication date
Field of study
Get PDF
Crossref
PubMed Central
Get PDF
